Gondaliya P, Zinn DA, Sayyed AA, Driscoll J, Yan IK, Mensali N, Wälchli S, Patel T (2026)
Engineered Natural Killer Cell Derived-Extracellular Vesicles: An Acellular Immunotherapy with Cytotoxic Effects in SNU-1079 Human Cholangiocarcinoma Cells
Mol Pharm, 23 (9), 4540-4552
DOI 10.1021/acs.molpharmaceut.6c00219, PubMed 42704135

Krawczyk M, Fidyt K, Fernandez-Fuentes N, Winiarski T, Pepek M, Bousquets-Muñoz P, Puente XS, Gutiérrez-Fernández A, Davis J, Owczarek D, Graczyk-Jarzynka A, Sanz-Galarreta P, Menendez P, Szumera-Ciećkiewicz A, Benard E, Wälchli S, Thomas-Tikhonenko A, Pérez-García VM, Galán-Gómez V, Escudero López A, Delgado EI, Minguillón J, Pérez-Martínez A, Winiarska M (2026)
Tisa-cel and axi-cel CAR structure influences the development of resistance to CD19-CAR-T therapy
Leukemia (in press)
DOI 10.1038/s41375-026-03081-3, PubMed 42660975

Rovesti G, Woodbridge AF, Yao H, Pancaldi A, Chiavelli C, Gatto F, Sandvick U, Sällberg M, Fuxe J, Dominici M, Grönlund H, Nilsson OB, Nascimento Silva D, Pasetto A (2026)
Immunogenomic profiling reveals targets for gene therapy in pediatric brain tumors
Neurooncol Adv, 8 (1), vdag193
DOI 10.1093/noajnl/vdag193, PubMed 42592420